TRT, Retatrutide & HGH: The Complete Stack Guide

Your body runs testosterone on a chain of signals called the HPG axis, meaning the hypothalamus to pituitary to gonads line that connects the brain to the testes. The hypothalamus, a small region at the base of the brain, sends out a hormone called GnRH, meaning gonadotropin releasing hormone, down to the pituitary gland. The pituitary answers with two signals of its own. LH, meaning luteinizing hormone, tells the testes to make testosterone. FSH, meaning follicle stimulating hormone, mostly supports sperm production. Every link matters. If a signal upstream gets quieter, the testosterone at the end of the line drops with it.

The brain reads how much testosterone is in the blood and adjusts GnRH to match. When testosterone arrives from outside, the brain sees enough and turns its own signal down. LH and FSH fall, and the testes make less on their own. This is the expected mechanism on TRT, not a malfunction, and it is why a man on TRT typically shows low LH and FSH on a panel. Those two markers are how you confirm the axis is quiet for the expected reason rather than for a different one.

Total testosterone is everything in the blood, bound and unbound. Most of it rides around attached to a protein called SHBG, meaning sex hormone binding globulin, whose job is to hold on to testosterone and keep it out of circulation. Free testosterone, meaning the small share that is not bound to any protein, is the part your tissues can actually use. On TRT the total number is mostly set by what is injected, so it tends to stay steady. SHBG can still move, and when it rises it holds more of that total, so free testosterone falls while the total reads normal. That single detail explains more tired men on this stack than any other, and it is the first interaction in the next section.

Research suggests TRT is the most effective tool available for confirmed low testosterone in men. Not peptides, not supplements, and not lifestyle changes stacked on top of a baseline that is already depleted. It is the base of this stack because without an adequate floor the other two compounds are working inside a body that cannot fully respond to what they do. The data comes first though. A full panel at minimum covers total and free testosterone, LH, FSH, estradiol and SHBG, and research practice confirms the level is low before the floor is set.

A receptor is a docking point on a cell that a hormone or compound plugs into to deliver an instruction. Retatrutide plugs into three. The GLP-1 receptor, meaning glucagon like peptide 1, is the appetite and food noise receptor, and it also slows the stomach. The GIP receptor, meaning glucose dependent insulinotropic polypeptide, helps manage how the body handles and stores nutrients after a meal. Those two are the same receptors older compounds like semaglutide and tirzepatide work on, and research suggests they mostly do one thing, which is make you eat less. The third is the glucagon receptor. Glucagon is the hormone that tells the liver and fat tissue to release stored energy. Hitting that receptor tells the body to burn through what it has stored, not just take in less.

Older compounds work on one side of the equation. Intake goes down. Retatrutide works on both sides at the same time, intake down and output up. The exact size of the extra burn in humans is still being measured, but the direction of it is not in question. The result is a deeper total calorie deficit than most researchers plan for, and a deeper deficit is exactly what pulls on the other two legs. It raises SHBG, which lowers free testosterone. It asks more of recovery than HGH can cover past a point. And in a long deficit the thyroid tends to slow the whole engine to protect it. Every one of those is a short leg that gets blamed on the wrong compound.

The role of retatrutide in this stack starts as the metabolic reset. In the reset phase the goal is reaching a target weight and body composition, and the deficit is deliberately real. Once that point is reached, research practice describes the approach shifting from aggressive fat loss to ongoing metabolic support at a lower level, where the glucagon arm keeps metabolic rate and insulin sensitivity where they landed rather than driving further loss. The body shows the handoff point in a few ways. Strength holds instead of slipping, appetite returns enough to get protein in without effort, and the scale levels off while body composition stays where it is. The reset gets you there. Maintenance keeps you there. Running the reset deficit indefinitely is one of the more common reasons the retatrutide leg ends up short.

Growth hormone itself does not do most of the work people credit it with. It travels to the liver and tells it to make IGF-1, meaning insulin like growth factor 1, and IGF-1 is the messenger that drives tissue repair, recovery and holding on to lean mass. Growth hormone in the blood swings up and down within minutes, so a single growth hormone reading tells you very little. IGF-1 holds steady across the day, which is why it is the marker researchers use to see whether growth hormone is doing its job.

The body does not release growth hormone in a steady stream. It releases it in pulses, and the largest pulses come in the first stretch of deep sleep each night. Those pulses drive recovery between training sessions, tissue repair, sleep quality and the ability to hold muscle in a deficit. Research suggests the pulses weaken and thin out with age, which is why recovery takes longer every year after 40 even when training and protein are dialed in.

The pituitary reads IGF-1 the same way the brain reads testosterone. When IGF-1 is high because growth hormone is arriving from outside, the pituitary sees enough and sends its own pulses less often and less strongly. Research suggests this feedback turns natural output down over time, which is why HGH is not a compound that gets added casually and why it is the leg addressed last. Most researchers in this space, including the host, point first toward growth hormone peptides that ask the pituitary to release its own. HGH tends to produce faster and more visible results than those peptides because it does not depend on a signal that is already weakening, and that is also why its effect on natural output has to be respected.

HGH is the layer for men who have already set the floor with TRT and handled metabolic health, and who are now focused on recovery, tissue quality and the markers that separate aging well from just getting old. Added before the other two legs are in place, it supports recovery in a body that cannot fully respond, and it tends to get blamed for a wobble that another leg caused.

SHBG, meaning sex hormone binding globulin, is made in the liver, and the liver tends to make more of it when calories and insulin are low. In the published calorie restriction research, including a two year controlled trial and a review of randomized trials, SHBG rose under restriction in the trials that measured it, and free testosterone fell with it. On TRT the total testosterone is mostly set by what is injected, so it typically does not move when SHBG climbs. The free share does. More of the same total is held, and less is available to do anything.

A man on TRT whose total number is normal, often mid range, who feels like he is not on TRT at all. Drive flat, libido down, the gym heavy, mood grey. It tends to show up weeks into the deficit rather than at the start, which is why it gets pinned on the compound that started most recently.

Testosterone from outside the body can convert into estrogen, and that process is called aromatization, meaning an enzyme called aromatase, found mostly in fat tissue, rebuilds the testosterone molecule into estradiol, the main form of estrogen in men. What matters is not the estradiol number by itself. It is the balance between testosterone and estradiol, because the body reads the two against each other. That ratio can shift while testosterone still reads normal, in either direction. More fat tissue means more aromatase, so a heavier man tends to convert more. As retatrutide strips fat, the conversion can fall and the ratio can swing the other way, and estradiol that is too low tends to feel as flat as estradiol that is too high.

Ratio too far toward estradiol tends to read as water retention, moodiness, sleep that will not settle and libido gone. Ratio too far away from it tends to read as dry joints, flat mood, low libido and poor sleep. The overlap is the point. Both read as a short testosterone leg from the inside.

The GLP-1 receptor slows gastric emptying, meaning how fast the stomach moves food into the small intestine where it is absorbed. On retatrutide a meal eaten three hours ago may still be in the stomach, and nutrients may still be trickling into the blood for hours after a man would normally call himself fasted. Insulin stays up as long as nutrients keep arriving.

A growth hormone injection timed on an empty stomach that quietly is not empty. The timing that worked before retatrutide may not be the same timing now. The researcher feels nothing different at the moment of the injection and only notices the recovery leg getting shorter weeks later.

Insulin is the hormone that stores energy. Growth hormone is the hormone that releases it. When both are high at the same time the body gets two opposite instructions, and research suggests the fat releasing side of growth hormone is blunted while insulin is up, while the two together push harder on blood sugar than either does alone. A stomach that is not actually empty keeps insulin up, which changes what the same amount of HGH does. The same injection tends to do more for recovery and fat release when insulin is low and more for blood sugar when insulin is high.

HGH that seems to do less than it did before the GLP-1 started, with a fasting glucose reading that is drifting up at the same time.

Growth hormone tells the liver to release glucose and tells muscle and fat to burn fat instead of sugar, which leaves more sugar in the blood. In adults with diagnosed growth hormone deficiency, replacement therapy studies have reported higher fasting glucose and fasting insulin and a measurable drop in insulin sensitivity, most clearly in the first months. That matters for a man whose other compound is a GLP-1 agonist that is supposed to be improving insulin sensitivity. The two can cancel on that one marker while each does its own job elsewhere.

Usually nothing. This is the interaction that tends to show up in bloodwork before it shows up as anything you feel, which is why it is the one most often missed.

Testosterone tells muscle to hold protein. IGF-1 tells tissue to repair. Both signals protect lean mass in a deficit, but only up to a point, because past a certain depth of deficit the body is short of the raw material and the energy it needs to repair at all, and no hormone signal builds tissue out of nothing. Research suggests that is where the stack stops protecting muscle, and it is a short retatrutide leg, not a failure of the other two.

Strength numbers in the gym dropping week over week. Protein hard to get in because appetite is gone. And the scale still moving down, which makes it feel like everything is working. The scale moving is why most men miss this one. In the comment data researchers describe exactly this pattern, losing fat and muscle and strength together and watching the muscle come back once the deficit eased.

The body releases most of its own growth hormone in the first deep sleep of the night. Broken or short sleep removes those pulses. At the same time, research suggests outside HGH is already turning the natural output down. So a man with broken sleep is running HGH on top of a natural production that is quieter than it was for two reasons at once. The recovery leg gets shorter from both ends.

Sore for days after a normal workout. Sleep that does not feel restorative. Recovery that is worse on HGH than it was before, which makes no sense until the sleep is accounted for.

Hematocrit, meaning the share of your blood made of red cells, tends to rise on testosterone because testosterone causes a temporary spike in erythropoietin, meaning the hormone from the kidneys that tells the bone marrow to make red blood cells. More red cells make the blood thicker, and thicker blood is harder to push. The Endocrine Society guideline treats hematocrit as one of the two numbers it tracks on testosterone therapy, and it holds therapy when hematocrit goes above 54 percent until it comes down. Sleep apnea and dehydration tend to push it higher still, and both are common in this audience.

Headaches, a flushed face, blood pressure creeping up, and sometimes a thick or sluggish feeling that reads as tired. This is the one leg where the wobble is a safety signal rather than a performance signal.

The thyroid sets the idle speed of the whole body. In a long deficit the body protects itself by converting less of the storage form of thyroid hormone, T4, into the active form, T3, meaning the one that actually tells cells to burn energy. Research suggests free T3 tends to fall in a sustained deficit while TSH, meaning thyroid stimulating hormone, the signal from the pituitary, often stays in range. The engine idles lower. None of the three compounds addresses that, and it tends to make all three look like they stopped working at once.

Cold hands and feet. Tired regardless of what or when you eat. Slow everywhere, slow thinking, slow bowels, slow pulse, hair thinning. The whole stool wobbles and no single leg looks short.

The phase 2 retatrutide trial published in the New England Journal of Medicine reported heart rate rising with the amount used, peaking around week 24 and easing after. Researchers tie the rise to the glucagon arm speeding up energy use, and the glucagon receptor is present in heart tissue. A resting heart rate that is up through the night tends to fragment sleep, especially when the injection lands so that the activity window falls over sleeping hours. Fragmented sleep removes the deep sleep where growth hormone release happens, which is the previous interaction all over again, triggered by a different leg.

Researchers in the comment data describe this in their own words, that the increased resting heart rate seriously impacted their sleep quality, and that they could not shake the insomnia. The tired feeling that follows gets blamed on retatrutide directly, when the real chain is heart rate to sleep to a short recovery leg.

Part one described men the host has spoken to running 400 to 500 milligrams of testosterone a week. Most had energy through the day, but their sleep was destroyed and their libido was gone. As soon as they brought the amount down, everything corrected. Energy stayed, sleep came back, libido came back. The high amount was creating the exact problems they thought testosterone was supposed to fix.

The more testosterone in the blood, the more raw material aromatase has to turn into estradiol, meaning the main form of estrogen in men. Past a point the ratio tips far toward estradiol, and research suggests libido in men depends on that balance rather than on testosterone alone. A man with a testosterone number three times his old peak can feel less drive than he did before he started, because the ratio, not the number, is what the body reads.

Three things tend to stack up at night. Estradiol that runs high is associated with water retention and restless sleep. Hematocrit climbs as testosterone drives red cell production, and the guideline asks clinicians to check for sleep apnea, meaning breathing that stops and starts during sleep, when hematocrit runs high, because the two feed each other. And testosterone itself can worsen existing sleep apnea, which the Endocrine Society guideline lists as a reason for caution before starting. The result is a man who feels wired by day and wrecked by night.

High androgen levels tend to lower HDL, meaning the cholesterol carrier usually linked to protection, and tend to raise blood pressure, partly through the thicker blood and partly through water retention. Neither produces a symptom until it has been running for a while, which is why they are on the panel and not on the symptom check.

On any amount of outside testosterone the HPG axis goes quiet, but the higher the amount, the harder and longer it tends to stay quiet. A man who cycles off a performance level lands in a window where outside testosterone has cleared and his own signal has not come back, and that window is where the crash is felt. At a replacement level run continuously there is no window to fall into, because nothing forces the stop.

On retatrutide, performance is not mainly about the amount on the label. It is about how deep the deficit runs and how long it is held. The glucagon arm means intake down and output up at the same time, so the compound can create a deeper deficit than most men plan for, and the temptation is to read a faster dropping scale as a better result. Based on the data, it usually is not.

First, the stomach. In the phase 2 trial, stomach side effects rose with the amount and were partly reduced by a lower starting level, which is why the trial climbed slowly. Second, the heart rate, which rose with the amount and peaked around week 24, and which tends to break sleep and shorten the recovery leg. Third, lean mass. Past a certain depth TRT and IGF-1 stop protecting muscle, and strength drops while the scale keeps moving. Fourth, SHBG climbs and free testosterone falls on a total that still reads normal. Fifth, in a long deficit the thyroid converts less T4 to T3 and the whole engine idles lower. Every one of those is a short leg, and every one was caused by pushing the metabolic leg, not by failing to push it hard enough.

The reset is supposed to be a phase. Held indefinitely, the deficit keeps pulling on the other two legs long after the fat it was meant to remove is gone. The longevity version moves to maintenance once the target body composition is reached, where the glucagon arm keeps metabolic rate and insulin sensitivity where they landed instead of driving further loss. Research on stopping GLP-1 compounds altogether tends to show weight returning, which is the other reason maintenance exists. It is the alternative to both extremes, running the reset forever or stopping cold.

Part one described researchers running 4 IU of HGH a day with no other compounds supporting it. They cycled off, and when they came back they only needed 1 IU to get the results they were looking for. Four times the amount, four times the cost, and months of unnecessary suppression risk for results available at a quarter of it.

The result men want from growth hormone runs through IGF-1, and IGF-1 does not climb in a straight line forever. Once the liver is making enough of it to cover repair and recovery, more growth hormone mostly adds the side effects without adding much of the result. In UK NICE guidance for adults with diagnosed growth hormone deficiency, the median maintenance amount is 1.2 IU a day, adjusted to keep IGF-1 in the middle of the age range, and older adults are given less. The 4 IU researcher was running more than three times that, which is why dropping to 1 IU changed nothing except the side effects.

Growth hormone pulls water into tissue, so the first signs tend to be puffy hands, swollen ankles and joints that ache. The same fluid presses on the median nerve, meaning the nerve that runs through the wrist into the hand, which is where the numb fingers at night come from, a carpal tunnel pattern. Growth hormone also tells the liver to release glucose and makes muscle and fat less responsive to insulin, so fasting glucose and fasting insulin tend to climb. On a stack whose metabolic leg is a GLP-1 agonist meant to improve insulin sensitivity, that pulls the two legs against each other.

The pituitary reads IGF-1 and sends fewer and weaker pulses while outside growth hormone keeps it up. The higher IGF-1 runs above the age range, the harder that feedback tends to press. Natural output after 40 is already weaker than it was, so a man who suppresses it hard and then stops comes back to a signal that was fading to begin with. A moderate amount that keeps IGF-1 mid range tends to ask less of that feedback, which is part of why it can be run continuously.